HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictors of extra-articular manifestations in rheumatoid arthritis.

AbstractOBJECTIVE:
To identify clinical and genetic risk factors for extra-articular manifestations of rheumatoid arthritis (ExRA).
METHODS:
ExRA patients were identified retrospectively using predefined criteria in two hospital-based cohorts of RA patients, and compared to non-extraarticular RA controls from one of the cohorts, matched for disease duration.
RESULTS:
Forty-nine living and thirteen deceased cases of ExRA were identified. Extra-articular disease was predicted by the demonstration of antinuclear antibodies (Odds ratio (OR) 3.6; 95% CI: 1.4-9.1) and the presence of rheumatoid nodules within two years from RA diagnosis (OR 3.4; 95%, CI: 1.1-10.9) or at any time before ExRA onset (OR 2.8; 95% CI: 1.1-7.2). Male sex and rheumatoid factor did not affect the risk of ExRA. Although present in the majority of cases as well as controls, the disease associated HLA-DRB1 subtypes were not significant predictors of ExRA.
CONCLUSION:
Extra-articular manifestations of rheumatoid arthritis in a hospital based population were predicted by antinuclear antibodies and rheumatoid nodules.
AuthorsC Turesson, L Jacobsson, U Bergström, L Truedsson, G Sturfelt
JournalScandinavian journal of rheumatology (Scand J Rheumatol) Vol. 29 Issue 6 Pg. 358-64 ( 2000) ISSN: 0300-9742 [Print] England
PMID11132204 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Antinuclear
  • HLA-DR Antigens
  • HLA-DRB1 Chains
Topics
  • Adolescent
  • Adult
  • Antibodies, Antinuclear (analysis)
  • Arthritis, Rheumatoid (complications, immunology)
  • Child
  • Cohort Studies
  • Female
  • HLA-DR Antigens (analysis)
  • HLA-DRB1 Chains
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Rheumatoid Nodule (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: